Key Points
- Insider Thomas Lynch sold 35,112 Billiontoone shares for approximately $3.87 million under a pre-arranged Rule 10b5-1 trading plan, reducing his holdings by 98.05% to 700 shares.
- Billiontoone reported quarterly revenue of $109.45 million and earnings of $0.15 per share, matching analyst expectations. The stock opened at $103.86, down 1.9%, with a market capitalization of about $4.90 billion.
- Analyst sentiment is mixed: the consensus rating is Hold with a $125.88 price target, while recent price targets were lowered and Zacks downgraded the stock to “strong sell.”
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) insider Thomas Lynch sold 35,112 shares of the company's stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $110.33, for a total value of $3,873,906.96. Following the completion of the transaction, the insider owned 700 shares of the company's stock, valued at approximately $77,231. This represents a 98.05% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Billiontoone Trading Down 1.9%
BLLN opened at $103.86 on Tuesday. The firm's 50 day moving average is $109.42 and its 200-day moving average is $97.24. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $150.44. The company has a quick ratio of 11.31, a current ratio of 11.69 and a debt-to-equity ratio of 0.17. The firm has a market capitalization of $4.90 billion and a P/E ratio of 148.37.
Billiontoone (NASDAQ:BLLN - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The business had revenue of $109.45 million during the quarter. Analysts expect that Billiontoone, Inc. will post 0.83 EPS for the current fiscal year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of BLLN. MCF Advisors LLC lifted its stake in shares of Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company's stock valued at $54,000 after purchasing an additional 344 shares during the last quarter. Integrated Wealth Concepts LLC acquired a new position in Billiontoone during the second quarter worth $29,000. Thrive Wealth Management LLC acquired a new position in Billiontoone during the second quarter worth $240,000. Jasper Ridge Partners L.P. bought a new position in Billiontoone during the second quarter valued at about $615,000. Finally, Wasatch Advisors LP lifted its position in shares of Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company's stock worth $62,160,000 after buying an additional 148,446 shares during the last quarter.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the stock. JPMorgan Chase & Co. reduced their price target on shares of Billiontoone from $145.00 to $130.00 and set an "overweight" rating on the stock in a research report on Thursday, August 6th. Zacks Research cut Billiontoone from a "hold" rating to a "strong sell" rating in a research note on Monday, August 31st. Weiss Ratings upgraded Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a report on Tuesday, June 23rd. BTIG Research cut their target price on Billiontoone from $142.00 to $130.00 and set a "buy" rating on the stock in a research report on Thursday, August 6th. Finally, Canaccord Genuity Group initiated coverage on Billiontoone in a research report on Wednesday, September 2nd. They issued a "buy" rating and a $120.00 price target for the company. Seven research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $125.88.
Read Our Latest Analysis on Billiontoone
Billiontoone Company Profile
(
Get Free Report)
BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company's technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.
The company's primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
